Skip to Content
Merck
CN
  • Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement.

Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (2013-01-12)
Jianjun Zhang, Yanting Huang, Dapeng Liu, Yuan Gao, Shuai Qian
ABSTRACT

The aim of the study was to investigate the potential of nanocrystals to enhance the oral bioavailability of apigenin (AP), a bioactive flavonoid with various pharmacological activities but poor aqueous solubility. In the present investigation, the AP nanocrystals were prepared by the supercritical antisolvent process. In vitro characterization was performed by scanning electron microscopy, FT-IR, differential scanning calorimetry, X-ray powder diffractometry. In vitro dissolution of prepared nanocrystals was studied and compared with untreated coarse powder. In addition, the pharmacokinetic study of AP nanocrystals, in comparison to coarse powder, was also performed in rats after a single oral dose. The prepared AP nanocrystals, without change in crystalline structure, appeared in spherical shape with particle size of about 400-800 nm. The reduction of particle size resulted in a more rapid dissolution of AP from nanocrystals than from coarse powder. In comparison to coarse powder, AP nanocrystals exhibited a significantly decreased t(max), a 3.6-fold higher peak plasma concentration (C(max)) and 3.4-fold higher area under the curve (AUC).

MATERIALS
Product Number
Brand
Product Description

Supelco
Apigenin, analytical standard
Sigma-Aldrich
Apigenin, ≥95.0% (HPLC)